Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

Sacro-Iliac Spondylosis Clinical Trial

Official title:
Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection

Status Terminated

Clinical Trial Summary

Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections

Clinical Trial Description

Patients eligible for a sacroiliac joint injection will be randomized to receive one of two different steroids, dexamethasone or triamcinolone. The response immediately after injection will be assessed to confirm the diagnosis, and then they will be followed for three month to assess the degree of pain relief experienced ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03166761
Study type	Interventional
Source	Vanderbilt University Medical Center
Contact
Status	Terminated
Phase	Phase 4
Start date	September 14, 2017
Completion date	February 28, 2023

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04446988` - Ultrasound Versus Fluoroscopic Guided Sacroiliac Joint Injection In Patients With Chronic Sacroiliac Joint Pain	N/A
	Recruiting	`NCT06268704` - Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection	Phase 4